FCM
SRPT icon

Frontier Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Frontier Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-53,443
Closed -$3.41M – 307
2025
Q1 		$3.41M Buy
53,443
+17,881
+50% +$1.88M 0.04% 267
2024
Q4 		$4.32M Sell
35,562
-4,735
-12% -$580K 0.04% 259
2024
Q3 		$5.03M Sell
40,297
-902
-2% -$125K 0.05% 250
2024
Q2 		$6.51M Sell
41,199
-33,998
-45% -$4.37M 0.06% 238
2024
Q1 		$9.73M Buy
75,197
+22,570
+43% +$2.76M 0.09% 219
2023
Q4 		$5.07M Sell
52,627
-8,544
-14% -$820K 0.05% 232
2023
Q3 		$7.42M Sell
61,171
-48,149
-44% -$5.44M 0.08% 208
2023
Q2 		$12.5M Sell
109,320
-119,823
-52% -$15.5M 0.12% 182
2023
Q1 		$31.6M Sell
229,143
-32,555
-12% -$4.22M 0.33% 117
2022
Q4 		$33.9M Sell
261,698
-22,252
-8% -$2.58M 0.37% 106
2022
Q3 		$31.4M Sell
283,950
-164,130
-37% -$16.5M 0.37% 100
2022
Q2 		$33.6M Sell
448,080
-45,916
-9% -$3.38M 0.39% 98
2022
Q1 		$38.6M Sell
493,996
-60,327
-11% -$4.62M 0.35% 105
2021
Q4 		$49.9M Sell
554,323
-78,356
-12% -$6.7M 0.39% 86
2021
Q3 		$58.5M Buy
632,679
+17,099
+3% +$1.32M 0.46% 73
2021
Q2 		$47.9M Buy
+615,580
New +$46.7M 0.35% 111
2018
Q2 		– Sell
-228,640
Closed -$16.9M – 326
2018
Q1 		$16.9M Buy
+228,640
New +$15.2M 0.12% 205

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Frontier Capital Management's SRPT Position: Q2 2025 in Review

Frontier Capital Management sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 53,443 shares — an estimated $3.41M sold.

Frontier Capital Management first reported a position in SRPT in Q1 2018 and held it in 17 quarters. The position peaked at $58.5M in Q3 2021. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Frontier Capital Management reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Frontier Capital Management sold 53,443 Sarepta Therapeutics shares in Q2 2025, an estimated $3.41M.
  • Frontier Capital Management first reported a position in Sarepta Therapeutics in Q1 2018 and held it in 17 quarters.
  • Frontier Capital Management's Sarepta Therapeutics position peaked at $58.5M in Q3 2021.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Frontier Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.